A textbook case of outmaneuvering, indeed. What GILD did in creating Truvada could’ve easily been done by GSK, Roche, or BMY, among others. I’ll bet there were mid-level people at those companies who proposed such an idea only to see it lost in the bureaucratic maze.
Market Data 
Markets 
AI
